Resveratrol activates p65 by phosphorylating Thr464 via the PKC activation of PKG, promoting interaction between p65 and PGC-1a, which, in turn, inactivates PGC-1a, reduces mitochondrial content and induces hepatic steatosis. The gene discussed is PPARGC1A; the disease is fatty liver disease.